US Investment Near $1 B Fails to Achieve Domestic Medical Glove Production

Bloomberg examines the U.S. effort to create a fully domestic supply of medical gloves. Nearly $1 billion in public and private funding has been allocated to the project. Despite the investment, manufacturers still rely on overseas materials and processes. Regulatory hurdles and limited raw material sources hinder domestic production. The shortage of skilled labor further complicates scaling up glove factories. Policy makers cite national security and pandemic resilience as motivations. The report suggests that current strategies may be insufficient to meet demand. Stakeholders are urged to reassess supply chain incentives and regulatory frameworks.